TG Therapeutics Inc (TGTX)
16.19
-0.23
(-1.40%)
USD |
NASDAQ |
May 03, 16:00
16.21
+0.02
(+0.12%)
After-Hours: 20:00
TG Therapeutics Debt to Equity Ratio: 0.00 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2024 | 0.00 |
December 31, 2023 | 0.6238 |
September 30, 2023 | 0.00 |
June 30, 2023 | 2.415 |
March 31, 2023 | 3.518 |
December 31, 2022 | 1.214 |
September 30, 2022 | 0.697 |
June 30, 2022 | 0.5343 |
March 31, 2022 | 0.3947 |
December 31, 2021 | 0.2857 |
September 30, 2021 | 0.0514 |
June 30, 2021 | 0.0604 |
March 31, 2021 | 0.0677 |
December 31, 2020 | 0.0576 |
September 30, 2020 | 0.1738 |
June 30, 2020 | 0.1515 |
March 31, 2020 | -21.58 |
December 31, 2019 | 0.7502 |
September 30, 2019 | -1.114 |
June 30, 2019 | 2.159 |
March 31, 2019 | 1.469 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.0013 |
June 30, 2018 | 0.0021 |
March 31, 2018 | 0.0026 |
Date | Value |
---|---|
December 31, 2017 | 0.0019 |
September 30, 2017 | 0.0023 |
June 30, 2017 | 0.002 |
March 31, 2017 | 0.0017 |
December 31, 2016 | 0.0019 |
September 30, 2016 | 0.0021 |
June 30, 2016 | 0.0012 |
March 31, 2016 | 0.0017 |
December 31, 2015 | 0.0021 |
September 30, 2015 | 0.0016 |
June 30, 2015 | 0.0026 |
March 31, 2015 | 0.0026 |
December 31, 2014 | 0.0034 |
September 30, 2014 | 0.0027 |
June 30, 2014 | 0.0031 |
March 31, 2014 | 0.0021 |
December 31, 2013 | 0.0185 |
September 30, 2013 | 0.066 |
June 30, 2013 | 0.2961 |
March 31, 2013 | 0.211 |
December 31, 2012 | 0.203 |
September 30, 2012 | 0.5397 |
June 30, 2012 | 0.4605 |
March 31, 2012 | 0.4551 |
December 31, 2011 | 0.4335 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-21.58
Minimum
Mar 2020
3.518
Maximum
Mar 2023
-0.4771
Average
0.2298
Median
Debt to Equity Ratio Benchmarks
Amicus Therapeutics Inc | 2.422 |
Geron Corp | 0.2399 |
Editas Medicine Inc | 0.00 |
G1 Therapeutics Inc | 1.457 |
Mersana Therapeutics Inc | 0.6837 |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 373.32M |
Total Liabilities (Quarterly) | 213.21M |
Shareholders Equity (Quarterly) | 1.525B |
Current Ratio | 5.918 |
Net Debt Paydown Yield | 0.61% |